Evidence-Based Medicine
Epilepsy in Children
Background
- The International League Against Epilepsy (ILAE) defines epilepsy as a disease of the brain defined by the following:
- 2 or more unprovoked or reflex seizures occurring > 24 hours apart
- single unprovoked (or reflex) seizure and high-risk of recurrence over the next 10 years
- diagnosis of an epilepsy syndrome
- The ILAE classifies seizures as 1 of 3 types (focal, generalized, and unknown) with optional subclassifications based on additional features.
- Some of the risk factors for the development of epilepsy in children may include traumatic brain injury, pregnancy-related factors, and birth-related factors.
- The causes of epilepsy can be divided into several categories by age of onset, genetic, structural, metabolic, and other (idiopathic, autoimmune, distinctive constellations, and infection).
- Epilepsy may resolve in children:
- with age-dependent epilepsy syndrome who have aged past applicable age range
- who become seizure free after first prescribed drug
- who are free of seizure for preceding 10 years and no longer taking seizure medication for ≥ 5 years
Evaluation
- Perform a complete history and thorough physical examination on all children suspected of epilepsy.
- The clinical presentation of epilepsy in children is quite variable and depends on the age of the patient and type of seizure.
- Differentiate true epileptic events (seizures) from nonepileptic events.
- Obtain an interictal electroencephalogram (EEG), with hyperventilation and photic stimulation, after a second epileptic seizure to support an epilepsy diagnosis.
- Consider neuroimaging with brain magnetic resonance imaging (MRI), which is the modality of choice, or computed tomography (CT), to classify the seizure type and/or to identify an underlying etiology.
- In patients with an unclear diagnosis consider blood testing, electrocardiography (ECG), or other diagnostic testing.
Management
- The goals of management for epilepsy in children are seizure control with minimal adverse events, and supporting quality of life; management considers epilepsy syndrome, seizure type, and patient characteristics, including age, sex, and comorbidities if present.
- The treatment of epilepsy in children should be initiated by a specialist.
- Begin treatment with antiseizure medications (ASMs) where the selection is dependent on the diagnosed seizure type or syndrome.
- For ASM medically refractory epilepsy, consider:
- other medications such as
- immunomodulators
- pyridoxine
- cannabidiol
- dietary management
- surgical management
- vagus nerve stimulation
- complementary and alternative therapies
- other medications such as
- Offer counseling to patients and/or caregivers to emphasize the importance of following the treatment regimen for seizure control.
- Assess the response to treatment at regular intervals.
- Do not routinely monitor lab work unless clinically indicated or recommended by a specialist.
- Consider gradual ASM discontinuation after ≥ 2 years of seizure freedom.
Published: 09-07-2023 Updeted: 09-07-2023
References
- Moshé SL, Perucca E, Ryvlin P, Tomson T. Epilepsy: new advances. Lancet. 2015 Mar 7;385(9971):884-98
- Glauser TA, Loddenkemper T. Management of childhood epilepsy. Continuum (Minneap Minn). 2013 Jun;19(3 Epilepsy):656-81
- National Institute for Health and Clinical Excellence (NICE). The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care. NICE 2012 Jan:CG137 (PDF), updated April 2018